Edition:
India

Panacea Biotec Ltd (PNCA.BO)

PNCA.BO on Bombay Stock Exchange

231.90INR
18 Oct 2017
Change (% chg)

-- (--)
Prev Close
Rs231.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,869
52-wk High
Rs265.55
52-wk Low
Rs103.00

Chart for

About

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations. The Company's segments include Vaccines, Formulations, Research and Development; Healthcare and Real estate activities. Its Vaccines, Formulations and Research &... (more)
No analyst recommendations are available for .

Overall

Beta: 0.50
Market Cap(Mil.): Rs14,182.61
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.62 17.08
EPS (TTM): -- -- --
ROI: -- 14.92 11.26
ROE: -- 16.18 15.09

BRIEF-Panacea Biotec gets GMP compliance certificate from state service of Ukraine on Medicines and Drug Control‍​

* Panacea Biotec - gets certificate of GMP compliance from state service of Ukraine on Medicines and Drug Control‍​

17 Oct 2017

BRIEF-India's Panacea Biotec June-qtr loss widens

* June quarter net loss 479.9 million rupees versus loss 204.9 million rupees year ago

13 Sep 2017

BRIEF-Panacea Biotec expands collaboration with Apotex to launch prasugrel in US

* Says expands collaboration with Apotex to launch prasugrel in US

11 Sep 2017

BRIEF-Panacea Biotec entered into joint collaboration agreement with Bionpharma Inc

* Entered into joint collaboration for development, license, among others for 7 complex generic pharmaceutical products with Bionpharma Inc Source text for Eikon: Further company coverage:

28 Jul 2017

Morning News Call - India, April 24

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_04242017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 3:45 pm: Farm Minister Radha Mohan Singh at an event in New Delhi. LIVECHAT-COMMODITIES From copper to oil and everything in between, the Gold & Silver Club's Nik Kalsi and Phil Carr wil

24 Apr 2017

Deals of the day-Mergers and acquisitions

April 21 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

22 Apr 2017

Narayana Hrudayalaya to buy NewRise Healthcare

Healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

India's Narayana Hrudayalaya to buy NewRise Healthcare

April 21 Indian healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

21 Apr 2017

BRIEF-Narayana Hrudayalaya enteres deal to buy Newrise Healthcare

* Says entered deal to buy 100 percent stake in Newrise Healthcare from Panacea Biotec and Panera Biotec

21 Apr 2017

Earnings vs. Estimates

No consensus analysis data available.